Rapidly progressive diabetic kidney disease: South Asian experience

ConclusionYounger age, higher body mass index, coexisting hypertension, overt proteinuria, and suboptimal glycemic and blood pressure control with underutilization of RAS inhibitors were prevalent in rapid decliners in DKD. Rapidly progressive diabetic kidney disease is a globally under-recognized entity, and this is the first experience shared from the South Asian region.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research

Related Links:

This study aimed to detect patients ’ characteristics who suffered severe and critical COVID-19 pneumonia admitted to the post-acute COVID-19 rehabilitation clinic in Ankara City Hospital, Physical Medicine and Rehabilitation Hospital and to share our experiences and outcomes of rehabilitation programmes applied. This study was desi gned as a single-centre, retrospective, observational study. Severe and critical COVID-19 patients, admitted to the post-acute COVID-19 rehabilitation clinic, were included in patient-based rehabilitation programmes, targeting neuromuscular and respiratory recovery. Functional status, oxy...
Source: Rheumatology International - Category: Rheumatology Source Type: research
ConclusionsResults suggest that psychological distress and lower HRQoL should be taken into account while promoting a healthy diet in overweight or obese CRC survivors since these factors may hinder adherence to a healthy diet.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11. In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the youngest group yet to potentially get immunized against the disease in the US. The committee recommended a two-dose regimen at one-third the dosage approved for adults. The FDA now takes the committee’s advice into consideration before making a final recommendation. If the agency decides to recommend th...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Mr. Williams is a 52-year old male who has been following me for some time. He has just been started on metformin for newly diagnosed diabetes. Lisinopril is his only other medication for high blood pressure. When he had his yearly physical, he was also found to have a high LDL“bad” cholesterol of 150.Read more …The dream patient that makes a doctor very happy originally appeared inKevinMD.com.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Conditions Cardiology Source Type: blogs
FDA OCI, Duniel Tejeda, Canon City CO, Miami FL, falsify, drug, clinical trial, data, Tellus Clinical Research, medical clinic, project manager, study coordinator, opioid dependency, irritable bowel syndrome, diabetic nephropathy, subjects, not participating,
Source: Office of Criminal Investigations (OCI) Press Releases - Category: Medical Law Authors: Source Type: news
Condition:   Obesity Intervention:   Procedure: Stomach Intestinal Pylorus-Sparing (SIPS) Procedure Sponsor:   Bradley Needleman Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Obesity, Morbid Interventions:   Behavioral: Experimental Group 1: Enhanced VR intervention with body swapping + psychoeducational video + Treatment As usual;   Behavioral: Experimental Group 2: VR intervention without body swapping + psychoeducational video + Treatment As usual;   Behavioral: Control Group: Psychoeducational video + Treatment As usual Sponsors:   Hospital Universitari Vall d'Hebron Research Institute;   European Commission Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Carbohydrate;   Hypoxia;   Exercise;   Diabetes Mellitus, Type 2 Interventions:   Other: Exercise in normoxia;   Other: Control diet;   Other: Exercise in hypoxia;   Other: Low carbohydrate diet Sponsors:   Universidade do Porto;   Fundação para a Ciência e a Tecnologia;   University Institute of Maia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Discussion;   Other: Educational Intervention;   Other: Informational Intervention;   Other: Interview Sponsor:   M.D. Anderson Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Type2 Diabetes Intervention:   Device: BT-001 Sponsors:   Better Therapeutics;   Catalyst Health Network Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Congestive Heart Failure | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Hypertension | Insulin | Laboratory Medicine | Obesity | Proteinuria | Study | Urology & Nephrology